ID   JIP1_RAT                Reviewed;         708 AA.
AC   Q9R237; B0VXR5; O88979; Q9R1H8; Q9WVI5; Q9WVI6;
DT   05-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   05-DEC-2001, sequence version 2.
DT   24-JAN-2024, entry version 180.
DE   RecName: Full=C-Jun-amino-terminal kinase-interacting protein 1;
DE            Short=JIP-1;
DE            Short=JNK-interacting protein 1;
DE   AltName: Full=Islet-brain-1;
DE            Short=IB-1;
DE   AltName: Full=JIP-1-related protein;
DE            Short=JRP;
DE   AltName: Full=JNK MAP kinase scaffold protein 1;
DE   AltName: Full=Mitogen-activated protein kinase 8-interacting protein 1;
GN   Name=Mapk8ip1; Synonyms=Ib1, Jip1, Mapk8ip;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=9442013; DOI=10.1074/jbc.273.4.1843;
RA   Bonny C., Nicod P., Waeber G.;
RT   "IB1, a JIP-1-related nuclear protein present in insulin-secreting cells.";
RL   J. Biol. Chem. 273:1843-1846(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   STRAIN=Fischer; TISSUE=Fibroblast;
RA   Chen Y., Talmage D.;
RT   "JIP-1 related protein (JRP).";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=10098834; DOI=10.1046/j.1471-4159.1999.721335.x;
RA   Kim I.-J., Lee K.-W., Park B.Y., Lee J.-K., Park J., Choi I.Y., Eom S.-J.,
RA   Chang T.-S., Kim M.J., Yeom Y.I., Chang S.K., Lee Y.-D., Choi E.-J.,
RA   Han P.-L.;
RT   "Molecular cloning of multiple splicing variants of JIP-1 preferentially
RT   expressed in brain.";
RL   J. Neurochem. 72:1335-1343(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND INTERACTION WITH
RP   MAPK10.
RC   STRAIN=Sprague-Dawley; TISSUE=Heart;
RX   PubMed=21076496; DOI=10.1139/y10-088;
RA   Xu B., Zhou Y., Karmin O., Choy P.C., Pierce G.N., Siow Y.L.;
RT   "Regulation of stress-associated scaffold proteins JIP1 and JIP3 on the c-
RT   Jun NH2-terminal kinase in ischemia-reperfusion.";
RL   Can. J. Physiol. Pharmacol. 88:1084-1092(2010).
RN   [5]
RP   INTERACTION WITH SH3RF2.
RX   PubMed=22128169; DOI=10.1074/jbc.m111.269431;
RA   Wilhelm M., Kukekov N.V., Schmit T.L., Biagas K.V., Sproul A.A., Gire S.,
RA   Maes M.E., Xu Z., Greene L.A.;
RT   "Sh3rf2/POSHER protein promotes cell survival by RING-mediated proteasomal
RT   degradation of the c-Jun N-terminal kinase scaffold POSH (Plenty of SH3s)
RT   protein.";
RL   J. Biol. Chem. 287:2247-2256(2012).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-28, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 487-546, SH3 DOMAIN, AND SUBUNIT.
RX   PubMed=16456539; DOI=10.1038/sj.emboj.7600982;
RA   Kristensen O., Guenat S., Dar I., Allaman-Pillet N., Abderrahmani A.,
RA   Ferdaoussi M., Roduit R., Maurer F., Beckmann J.S., Kastrup J.S.,
RA   Gajhede M., Bonny C.;
RT   "A unique set of SH3-SH3 interactions controls IB1 homodimerization.";
RL   EMBO J. 25:785-797(2006).
CC   -!- FUNCTION: The JNK-interacting protein (JIP) group of scaffold proteins
CC       selectively mediates JNK signaling by aggregating specific components
CC       of the MAPK cascade to form a functional JNK signaling module. Required
CC       for JNK activation in response to excitotoxic stress. Cytoplasmic
CC       MAPK8IP1 causes inhibition of JNK-regulated activity by retaining JNK
CC       in the cytoplasm and thus inhibiting the JNK phosphorylation of c-Jun.
CC       May also participate in ApoER2-specific reelin signaling. Directly, or
CC       indirectly, regulates GLUT2 gene expression and beta-cell function.
CC       Appears to have a role in cell signaling in mature and developing nerve
CC       terminals. May function as a regulator of vesicle transport, through
CC       interactions with the JNK-signaling components and motor proteins.
CC       Functions as an anti-apoptotic protein and whose level seems to
CC       influence the beta-cell death or survival response. Acts as a scaffold
CC       protein that coordinates with SH3RF1 in organizing different components
CC       of the JNK pathway, including RAC1 or RAC2, MAP3K11/MLK3 or
CC       MAP3K7/TAK1, MAP2K7/MKK7, MAPK8/JNK1 and/or MAPK9/JNK2 into a
CC       functional multiprotein complex to ensure the effective activation of
CC       the JNK signaling pathway. Regulates the activation of MAPK8/JNK1 and
CC       differentiation of CD8(+) T-cells. {ECO:0000250|UniProtKB:Q9WVI9,
CC       ECO:0000269|PubMed:21076496}.
CC   -!- SUBUNIT: Forms homo- or heterooligomeric complexes (PubMed:16456539).
CC       Binds specific components of the JNK signaling pathway namely
CC       MAPK8/JNK1, MAPK9/JNK2, MAPK10/JNK3, MAP2K7/MKK7, MAP3K11/MLK3 and
CC       DLK1. Also binds the proline-rich domain-containing splice variant of
CC       apolipoprotein E receptor 2 (ApoER2). Interacts, via the PID domain,
CC       with ARHGEF28 (By similarity). Binds the cytoplasmic tails of LRP1 and
CC       LRP2 (Megalin). Binds the TPR motif-containing C-terminal of kinesin
CC       light chain, KLC1. Pre-assembled MAPK8IP1 scaffolding complexes are
CC       then transported as a cargo of kinesin, to the required subcellular
CC       location. Interacts with the cytoplasmic domain of APP (By similarity).
CC       Interacts with DCLK2, VRK2 and MAP3K7/TAK1. Found in a complex with
CC       SH3RF1, RAC1, MAP3K11/MLK3, MAP2K7/MKK7 and MAPK8/JNK1. Found in a
CC       complex with SH3RF1, RAC2, MAP3K7/TAK1, MAP2K7/MKK7, MAPK8/JNK1 and
CC       MAPK9/JNK2 (By similarity). Interacts with SH3RF2 (PubMed:22128169).
CC       {ECO:0000250|UniProtKB:Q9UQF2, ECO:0000250|UniProtKB:Q9WVI9,
CC       ECO:0000269|PubMed:16456539, ECO:0000269|PubMed:21076496,
CC       ECO:0000269|PubMed:22128169}.
CC   -!- INTERACTION:
CC       Q9R237-3; Q9R237-3: Mapk8ip1; NbExp=8; IntAct=EBI-8051913, EBI-8051913;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, perinuclear
CC       region {ECO:0000250}. Nucleus. Endoplasmic reticulum membrane
CC       {ECO:0000250}. Mitochondrion membrane {ECO:0000250}. Note=Accumulates
CC       in cell surface projections. Under certain stress conditions,
CC       translocates to the perinuclear region of neurons. In insulin-secreting
CC       cells, detected in both the cytoplasm and nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=JIP-1a, JIP-1b;
CC         IsoId=Q9R237-1; Sequence=Displayed;
CC       Name=2; Synonyms=JIP-1c, 2A;
CC         IsoId=Q9R237-2; Sequence=VSP_002767;
CC       Name=3; Synonyms=JIP-1d;
CC         IsoId=Q9R237-3; Sequence=VSP_002768, VSP_002769;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and pancreatic beta-
CC       cells. Weaker expression found in kidney.
CC   -!- DOMAIN: The SH3 domain mediates homodimerization.
CC   -!- PTM: Phosphorylated by MAPK8, MAPK9 and MAPK10. Phosphorylation on Thr-
CC       103 is also necessary for the dissociation and activation of MAP3K12.
CC       Phosphorylated by VRK2. Hyperphosphorylated during mitosis following
CC       activation of stress-activated and MAP kinases (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. Two preliminary events are required to prime for
CC       ubiquitination; phosphorylation and an increased in intracellular
CC       calcium concentration. Then, the calcium influx initiates
CC       ubiquitination and degradation by the ubiquitin-proteasome pathway (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the JIP scaffold family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD22543.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAD38351.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF108959; AAD22543.1; ALT_INIT; mRNA.
DR   EMBL; AF092450; AAC62110.1; -; mRNA.
DR   EMBL; AF109772; AAD38350.1; -; mRNA.
DR   EMBL; AF109773; AAD38351.1; ALT_INIT; mRNA.
DR   EMBL; AF109774; AAD38352.1; -; mRNA.
DR   EMBL; DQ377223; ABD24062.1; -; mRNA.
DR   RefSeq; NP_446229.1; NM_053777.1. [Q9R237-2]
DR   PDB; 2FPD; X-ray; 2.05 A; A/B/C/D=487-546.
DR   PDB; 2FPE; X-ray; 1.75 A; A/B/C/D/E/F/G/H=487-546.
DR   PDB; 2FPF; X-ray; 3.00 A; A/B/C/D=482-552.
DR   PDBsum; 2FPD; -.
DR   PDBsum; 2FPE; -.
DR   PDBsum; 2FPF; -.
DR   AlphaFoldDB; Q9R237; -.
DR   SMR; Q9R237; -.
DR   BioGRID; 250437; 2.
DR   IntAct; Q9R237; 6.
DR   MINT; Q9R237; -.
DR   STRING; 10116.ENSRNOP00000074684; -.
DR   iPTMnet; Q9R237; -.
DR   PhosphoSitePlus; Q9R237; -.
DR   jPOST; Q9R237; -.
DR   PaxDb; 10116-ENSRNOP00000065176; -.
DR   Ensembl; ENSRNOT00000079746.2; ENSRNOP00000074684.1; ENSRNOG00000058478.2. [Q9R237-2]
DR   Ensembl; ENSRNOT00000117436.1; ENSRNOP00000090670.1; ENSRNOG00000058478.2. [Q9R237-1]
DR   Ensembl; ENSRNOT00055028427; ENSRNOP00055022878; ENSRNOG00055016693. [Q9R237-1]
DR   Ensembl; ENSRNOT00060018527; ENSRNOP00060014407; ENSRNOG00060010920. [Q9R237-1]
DR   GeneID; 116457; -.
DR   KEGG; rno:116457; -.
DR   UCSC; RGD:70937; rat. [Q9R237-1]
DR   AGR; RGD:70937; -.
DR   CTD; 9479; -.
DR   RGD; 70937; Mapk8ip1.
DR   eggNOG; KOG3775; Eukaryota.
DR   GeneTree; ENSGT00940000157089; -.
DR   InParanoid; Q9R237; -.
DR   OrthoDB; 2904222at2759; -.
DR   PhylomeDB; Q9R237; -.
DR   TreeFam; TF325073; -.
DR   EvolutionaryTrace; Q9R237; -.
DR   PRO; PR:Q9R237; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000058478; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0044295; C:axonal growth cone; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0044294; C:dendritic growth cone; IDA:MGI.
DR   GO; GO:0044302; C:dentate gyrus mossy fiber; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008432; F:JUN kinase binding; IPI:RGD.
DR   GO; GO:0019894; F:kinesin binding; ISS:UniProtKB.
DR   GO; GO:0005078; F:MAP-kinase scaffold activity; IMP:RGD.
DR   GO; GO:0031434; F:mitogen-activated protein kinase kinase binding; IPI:RGD.
DR   GO; GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISS:UniProtKB.
DR   GO; GO:0007254; P:JNK cascade; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; IMP:RGD.
DR   GO; GO:0043508; P:negative regulation of JUN kinase activity; IMP:UniProtKB.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISS:UniProtKB.
DR   GO; GO:2000564; P:regulation of CD8-positive, alpha-beta T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0046328; P:regulation of JNK cascade; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0016192; P:vesicle-mediated transport; ISO:RGD.
DR   CDD; cd01212; PTB_JIP; 1.
DR   CDD; cd11943; SH3_JIP1; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   InterPro; IPR047178; JIP1_scaffold.
DR   InterPro; IPR035638; JIP1_SH3.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR006020; PTB/PI_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR47437:SF3; C-JUN-AMINO-TERMINAL KINASE-INTERACTING PROTEIN 1; 1.
DR   PANTHER; PTHR47437; JNK-INTERACTING PROTEIN 1-LIKE PROTEIN; 1.
DR   Pfam; PF00640; PID; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00462; PTB; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS01179; PID; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Endoplasmic reticulum;
KW   Membrane; Mitochondrion; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; SH3 domain; Ubl conjugation.
FT   CHAIN           1..708
FT                   /note="C-Jun-amino-terminal kinase-interacting protein 1"
FT                   /id="PRO_0000220630"
FT   DOMAIN          485..546
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          558..697
FT                   /note="PID"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00148"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          69..368
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          126..282
FT                   /note="JNK-binding domain (JBD)"
FT   REGION          154..173
FT                   /note="Minimal inhibitory domain (MID)"
FT   REGION          280..468
FT                   /note="Interaction with MAP3K7"
FT                   /evidence="ECO:0000250"
FT   REGION          426..448
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          468..657
FT                   /note="Interaction with VRK2"
FT                   /evidence="ECO:0000250"
FT   MOTIF           350..357
FT                   /note="D-box 1"
FT   MOTIF           361..369
FT                   /note="D-box 2"
FT   COMPBIAS        102..116
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        131..156
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        163..200
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        217..239
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        256..272
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        295..312
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         39
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         103
FT                   /note="Phosphothreonine; by MAPK8, MAPK9 and MAPK10"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         178
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         184
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         190
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         192
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         193
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         202
FT                   /note="Phosphothreonine; by MAPK8, MAPK9 and MAPK10"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         308
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         325
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         327
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         337
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         352
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         363
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         366
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         404
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         406
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         408
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         441
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         444
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         445
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         466
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         468
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         469
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   MOD_RES         470
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UQF2"
FT   VAR_SEQ         1..33
FT                   /note="MAERESGLSGGAASPPAASPFLGLHIASPPNFR -> MQLVLKMDSSPDNDS
FT                   WLEDQWERW (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10098834"
FT                   /id="VSP_002767"
FT   VAR_SEQ         69..93
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_002768"
FT   VAR_SEQ         708
FT                   /note="E -> EPMAQVQLQVDLEIKRAAAEQKLISEEDLNGAA (in isoform
FT                   3)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_002769"
FT   CONFLICT        38
FT                   /note="I -> V (in Ref. 2; AAC62110)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        149
FT                   /note="S -> C (in Ref. 1; AAD22543)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        384
FT                   /note="E -> D (in Ref. 4; ABD24062)"
FT                   /evidence="ECO:0000305"
FT   STRAND          490..492
FT                   /evidence="ECO:0007829|PDB:2FPE"
FT   STRAND          511..517
FT                   /evidence="ECO:0007829|PDB:2FPE"
FT   STRAND          521..527
FT                   /evidence="ECO:0007829|PDB:2FPE"
FT   TURN            528..530
FT                   /evidence="ECO:0007829|PDB:2FPE"
FT   STRAND          533..537
FT                   /evidence="ECO:0007829|PDB:2FPE"
FT   HELIX           538..540
FT                   /evidence="ECO:0007829|PDB:2FPE"
FT   STRAND          541..543
FT                   /evidence="ECO:0007829|PDB:2FPE"
SQ   SEQUENCE   708 AA;  77318 MW;  4923FD55F1C511F4 CRC64;
     MAERESGLSG GAASPPAASP FLGLHIASPP NFRLTHDISL EEFEDEDLSE ITDECGISLQ
     CKDTLSLRPP RAGLLSAGSS GSAGSRLQAE MLQMDLIDAA SDTPGAEDDE EDDDELAAQR
     PGVGPSKAES GQEPASRSQG QGQGPGTGSG DTYRPKRPTT LNLFPQVPRS QDTLNNNSLG
     KKHSWQDRVS RSSSPLKTGE QTPPHEHICL SDELPPQGSP VPTQDRGTST DSPCRRTAAT
     QMAPPSGPPA TAPGGRGHSH RDRIHYQADV RLEATEEIYL TPVQRPPDPA EPTSTFLPPT
     ESRMSVSSDP DPAAYSVTAG RPHPSISEED EGFDCLSSPE QAEPPGGGWR GSLGEPPPPP
     RASLSSDTSA LSYDSVKYTL VVDEHAQLEL VSLRPCFGDY SDESDSATVY DNCASASSPY
     ESAIGEEYEE APQPRPPTCL SEDSTPDEPD VHFSKKFLNV FMSGRSRSSS AESFGLFSCV
     INGEEHEQTH RAIFRFVPRH EDELELEVDD PLLVELQAED YWYEAYNMRT GARGVFPAYY
     AIEVTKEPEH MAALAKNSDW IDQFRVKFLG SVQVPYHKGN DVLCAAMQKI ATTRRLTVHF
     NPPSSCVLEI SVRGVKIGVK ADEAQEAKGN KCSHFFQLKN ISFCGYHPKN NKYFGFITKH
     PADHRFACHV FVSEDSTKAL AESVGRAFQQ FYKQFVEYTC PTEDIYLE
//
